›
^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersTEST:UltraSEEK® Colon Panel
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Agena BioType:
Laboratory Developed Test
Related tests:
The UltraSEEK® Colon Panel enables study of disease progression and resistance in colorectal cancer. Detect over 100 clinically relevant variants across BRAF, EGFR, KRAS, NRAS and PIK3CA. Indentify variants at as low as 0.1% variant allele frequency. se as little as 10 ng of cfDNA. 1 hour of hands-on time and 8 hours of total time
Cancer:
Colon Cancer
Gene:
BRAF (B-raf proto-oncogene), EGFR (Epidermal growth factor receptor), KRAS (KRAS proto-oncogene GTPase), NRAS (Neuroblastoma RAS viral oncogene homolog), PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha)
BRAF (B-raf proto-oncogene), EGFR (Epidermal growth factor receptor), KRAS (KRAS proto-oncogene GTPase), NRAS (Neuroblastoma RAS viral oncogene homolog), PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha)
